Get Permission Anandani, Manivannan, Sree Rekha J, Kar, and Basu: Patterns of bone marrow infiltration in lymphomas- A retrospective descriptive analysis from a tertiary care centre in Southern India


Introduction

Clinical and laboratory data along with imaging and evidence of BM infiltration on histopathological examination is needed for lymphoma staging. Histopathological examination of BMB remains the gold standard for lymphoma staging. BMB involvement upstages the case to stage IV. It is also required for evaluating the treatment response.1 WHO classifies lymphoma on the basis of morphology, immunophenotyping and molecular genetics characteristics into clinicopathologically distinct entities.2 Involvement of BM is seen in around 40% of cases of lymphomas. Presence or absence of BM infiltration, analysis of pattern of infiltration in BMB along with the morphology in BMA affects lymphoma diagnosis, prognosis and treatment. It also helps in selecting patients who may relapse early or fail to respond to treatment. It also rules out any other pathology in bone marrow.

This study evaluates various patterns of BMB infiltration by lymphomas which includes Hodgkin and non-Hodgkin lymphoma (NHL) and the usefulness of BMB is compared to BMA.3

Materials and Methods

This is a retrospective record based descriptive study of bone marrow biopsies done in patients with suspicion for diagnosis or staging of lymphomas. Cases in whom a previous BMA/BMB had been obtained showing bone marrow infiltration by lymphoma cells and came again for follow up were excluded.

 A total of 375 cases were evaluated for lymphoma infiltration in bone marrow from January 2015 to December 2018 including diagnostic as well as staging bone marrows. Diagnostic marrows included BMA/BMB involved by lymphomatous infiltration in patients without any history of lymphoma at any other site. Primary site of involvement was searched and identified after BMA/BMB showed lymphoma infiltration. Staging marrows included cases having a prior diagnosis of lymphoma showing lymphomatous infiltration in BMA/BMB either at the time of diagnosis or follow up. Of these, 212 cases which showed lymphoma infiltration in bone marrow, were included in this study. For each case, age, clinical details and diagnosis, complete hemogram determined by automated analyzer (Sysmex 5 part) and Romanowsky stained PBS and BMA smears were also studied along with the BMB. Serial sections of 3- 4 μm thickness were stained by hematoxylin and eosin (H and E) and reticulin stains and evaluated for adequacy, cellularity, trilineage hematopoeisis, presence of lymphomatous infiltration, its histologic pattern, morphology, and secondary changes like reticulin fibrosis and necrosis. Reticulin was graded from 0 to 3.2 Immunohistochemistry (IHC) was performed as and when indicated. In case of staging marrows, a basic panel was performed to confirm marrow infiltration. However in diagnostic cases, a complete panel was done.

Whether lymphoid nodules were neoplastic or reactive were differentiated on the basis of morphology and IHC. IHC for B- cell lymphoproliferative disorders (LPD) like CD20, CD79a, CD10, CD23, BCL2, BCL6, C-MYC along with CD3, CD5, CD7, CD4, CD8 for T- cell LPD were usually performed for typing and sub typing lymphomas. CD15, CD30, CD20 and PAX5 were used in cases of HL. Other IHC markers like CD34, terminal deoxy nucleotidase (TdT), leucocyte common antigen (LCA), CD99, CD38, CD138, kappa, lambda were performed wherever indicated.

Statistical analysis

The concordance between PBS, BMA and BMB slides was assessed in 209 cases in which PBS and BMA were available. Data were collected and a descriptive analysis was done. Quantitative results were expressed as mean (SD) and qualitative variables were expressed as frequency and percentages.

Patterns of involvement were classified as interstitial, nodular, mixed, paratrabecular, diffuse and intrasinusoidal. In interstitial infiltration neoplastic cells are interspersed between haematopoietic and fat elements. In spite of generalized BM involvement, trilineage hematopoeisis and architecture of BM is preserved. Nodular infiltration is oval or round lymphoid aggregates having a well-defined border in a non-paratrabecular location. Paratrabecular infiltration shows a band of lymphoid cells adjacent to the bony trabeculae or a broad based lymphoid aggregate adjoining the trabecula. In intrasinusoidal infiltration neoplastic cells are found within sinusoids. Diffuse or packed marrow pattern is effacement of BM architecture and absence of trilineage hematopoietic and fat cells which are replaced by lymphoid cells. Diffuse interstitial infiltration is seen in many lymphomas which indicates that there is widening of interstitium with loosely dispersed lymphoma infiltrate throughout the BM intertrabecular spaces. Mixed pattern denotes nodular- interstitial pattern (Figure 1). 4

Results

The study included 212 cases which showed lymphoma infiltration in BM. In this study 75% (159) of cases were male and 25% (53) were female patients constituting 3:1 male:female ratio. The age ranged between 3 to 84 years with mean age of 49.5 years. Amongst all 212 cases, the most common pattern of BM infiltration was diffuse 32.08% (68) followed by nodular 21.23% (45), mixed 18.40% (39), interstitial 17.93 (38), paratrabecular 8.01% (17) and sinusoidal 2.35% (5).

Amongst all the cases 87.27% (185) cases were NHL and 12.73% (27) cases were HL. 82.16% (152) of all NHL cases were B cell lymphomas and 17.84 (33) were T cell lymphomas. The most frequent lymphoma subtype infiltrating the BM was CLL/SLL (21.70%) followed by HL(12.73%)and FL(11.32%). Out of 27 cases of BM infiltration by HL, 25 cases were of classic Hodgkins lymphoma (CHL) and only 2 cases were of nodular lymphocyte predominant Hodgkins lymphoma (NLPHL). MCL, MZL, DLBCL, PTCL, BL and LPL were other commonly occurring lymphomas invading BM (Table 1). Low occurrence lymphomas were seen in 13.67% (29) of cases of which 5 were diagnosed as anaplastic large cell lymphoma (ALCL), 4 as hepatosplenic T cell lymphoma (HSTCL), 4 as HCL, 3 of T lymphoblastic lymphoma (T-LBL), 3 of B lymphoblastic lymphoma (B-LBL), 2 of plasmablastic lymphoma (PBL) and 2 of T- prolymphocytic leukemia (T-PLL). One case each of T- large granular lymphocytic leukemia/ lymphoma (T-LGL), NK-T cell leukemia/ lymphoma (NK-TCL), T cell rich B cell lymphoma (TCRBCL), angioimmunoblastic T cell lymphoma (AITCL), B- prolymphocytic leukemia (B-PLL) and splenic lymphoma with villous lymphocytes (SLVL) were studied.

CLL/SLL showed various types of patterns including interstitial, nodular, mixed and diffuse. However predominant pattern of infiltration was mixed followed by diffuse pattern. SLL or early CLL showed nodular pattern whereas late stage of CLL showed interstitial, mixed or diffuse patterns. Most common pattern of infiltration by FL was paratrabecular followed by few cases of nodular infiltration. One rare case of follicular lymphoma showed myelofibrosis along with paratrabecular and nodular pattern of infiltration. MCL showed either diffuse or nodular pattern. DLBCL and BL showed predominantly diffuse pattern. Predominant pattern of infiltration in HCL was interstitial. Most common pattern in PTCL was interstitial followed by diffuse pattern. Few cases of nodular pattern were also seen. The marrow was diffusely packed in LBL. MZLs of all types showed uniformly interstitial, nodular, paratrabecular and diffuse patterns. Most prominently mixed and interstitial followed by nodular, diffuse and sinusoidal. Sinusoidal pattern was seen only in SMZL and HSTCL. Out of five cases of ALCL two showed interstitial pattern and one case each showed nodular, diffuse and mixed pattern of infiltration. Most common pattern of infiltration in LPL was diffuse followed by interstitial. In HL, the pattern was usually focal nodular however diffuse involvement was seen in a few cases of nodular sclerosis and lymphocyte depleted types of HL. Diffuse involvement in HL included the Reed-Sternberg cells as well as the reactive population throughout the bone marrow (Table 1). IHC was used for differentiating reactive lymphoid aggregates from lymphoma infiltration and also to identify subtle foci of infiltration.

Out of 212 cases of BMB with infiltration, only 50.94%(108) cases had atypical lymphocytes or lymphocytosis in PBS and 81.14%(172) cases showed infiltration in BM. PBS and BMA slides were not available for three cases. PB involvement was infrequent in FL, DLBCL, T-cell lymphomas and absent in HL.

BMA showed no involvement in cases showing nodular infiltration in BMB as well as cases showing secondary stromal changes like fibrosis or necrosis. Some lymphomas like HL, HCL and few PTCL cases were non aspirable due to increased reticulin leading to dry tap so only BMB was required to assess marrow involvement. Stromal fibrosis was identified in 21.6% of cases commonest in HL, DLBCL, PTCL and HCL. One case of FL also showed stromal fibrosis (Figure 2). Necrosis was associated with 17.4% of cases comprising predominantly of DLBCL, BL and HL. One case of HL showed a dual lesion of lymphoma as well as tuberculosis confirmed by IHC and stain for Acid fast bacilli.

Out of all the positive BMB, 57.1% marrows were staging marrows and 42.9% were diagnostic marrows. Especially in HL, BL and MCL, 77.8%, 75% and 71.5% of all the positive marrows were staging marrows respectively (Table 2). Diagnostic marrows comprised of cases with unknown primary lymphoma which were predominantly small cell lymphomas. BMB along with immunophenotyping was very helpful for diagnosis of lymphoma, precluding the need for a lymph node biopsy especially if lymph nodes or the organ affected like spleen were not easily approachable. In 42.9% of our cases BMB was diagnostic of lymphoma and bone was the first site of tissue diagnosis. 66.7% of all positive cases of FL, 66.7% of LPL and 54.3% of CLL/SLL were diagnosed on BM examination.

Figure 1

Various patterns of lymphoma infiltration in bone marrow biopsy in H & E stain; a: Interstitial 4X; b: Nodular 10X; c: Mixed 4X; d: Diffuse 4X.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e280b340-e196-4a24-9e78-fcac914649f6image1.png
Figure 2

Paratrabecular infiltration of FL along with Myelofibrosis; a: 4X (H&E stain); b: 10X (H&E stain); c: Masson’s Trichrome showing myelofibrosis; d: IHC positivity for CD10 4X.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/e280b340-e196-4a24-9e78-fcac914649f6image2.png
Table 1

Distribution of various lymphoproliferative disorders showing BM infiltration along with their common patterns of BM involvement.

Lymphoma type

Frequency% (Number of cases)

Predominant pattern observed

CLL/SLL

21.70 (46)

Mixed, diffuse

HL

12.73 (27)

Focal nodular

FL

11.32 (24)

Paratrabecular

MCL

9.90 (21)

Diffuse, nodular

MZL

8.50 (18)

Mixed, interstitial

DLBCL

8.02 (17)

Diffuse

PTCL

7.54 (16)

Interstitial

BL

3.78 (8)

Diffuse

LPL

2.83 (6)

Diffuse

Others

13.67 (29)

ALCL

2.35 (5)

Interstitial

HSTCL

1.89 (4)

Sinusoidal

HCL

1.89 (4)

Interstitial

T-LBL

1.42 (3)

Diffuse

B-LBL

1.42 (3)

Diffuse

PBL

0.94 (2)

Diffuse, nodular

T-PLL

0.94 (2)

Mixed, interstitial

T-LGL

0.47 (1)

Interstitial

NK-TCL

0.47 (1)

Interstitial

TCRBCL

0.47 (1)

Diffuse

AITCL

0.47 (1)

Diffuse

B-PLL

0.47 (1)

Nodular

SMZL

0.47 (1)

Sinusoidal

Total

100 (212)

Table 2

BMB negative vs positive and diagnostic vs staging for lymphoma infiltration

BMB sent for lymphoma infiltration

Total BMB received

Positive for infiltration (%)

Positive for infiltration

Negative for infiltration

Diagnostic (%)

Staging (%)

CLL/SLL

53

46(86.8)

25(54.3)

21(45.7)

7(13.2)

HL

61

27(44.3)

6(22.2)

21(77.8)

34(55.7)

FL

34

24(70.6)

16(66.7)

8(33.3)

10(29.4)

MCL

25

21(84)

6(28.5)

15(71.5)

4(16)

MZL

38

18(47.4)

8(44.4)

10(55.6)

20(52.6)

DLBCL

60

17(28.3)

7(41.1)

10(58.9)

43(71.7)

PTCL

19

16(84.2)

1(6.3)

15(93.7)

3(15.8)

BL

16

8(50)

2(25)

6(75)

8(50)

LPL

8

6(75)

4(66.7)

2(33.3)

2(25)

Others

61

29(47.5)

16(55.2)

13(44.8)

32(52.5)

Total

375

212(56.6)

91(42.9)

121(57.1)

163(43.4)

Table 3

Comparison of infiltration patterns in various other studies.

Name of study

Year

Diffuse Pattern (%)

Nodular pattern (%)

Intersitial pattern (%)

Paratrabecular pattern (%)

Lim et al.

2000

71.4

0.0

0.0

0.0

Chen et al.

2000

22.0

7.0

23.0

0.0

Zhongura et al.

2006

44.9

29.3

11.6

0.0

Jamila et al.

2008

34

0.0

18

30

Lone et al.

2011

25

0.0

45

20

Cabezas-Quintario et al.

2016

6.3

6.5

7

4.4

Sultan et al.

2016

14.6

6.5

5.4

4.8

Present study

2018

32.08

21.23

17.93

8.01

Discussion

A similar study on 184 patients revealed that B cell lymphomas were more common than T cell lymphomas. However, unlike the present study, DLBCL constituted major subtype in 67.9% patients, followed by FL in 7.6% patients and MZL in 3.8% patients, MCL in 3.2%, ALCL in 2.7%, BL in 2.1% and TCRBCL in 2.1% patients. The lowest occurrence was of SLL in 1.6% patients. This was because they did not include cases of CLL in their study. 5

FL infiltrates the BM with a predominantly paratrabecular pattern. This is due to presence of CXCL4 which binds with its ligand CXCL12 in the osteoblastic niches located in the paratrabecular areas of BM. SMZL shows a predominantly intrasinusoidal infiltration due to presence of CD44 and integrins which interact with hyaluronan and ICAM-1 in endothelial cells. SMZL, HSTCL and HCL, mostly involve the spleen and the liver sinusoidal compartment which expose abundant hyaluronan similar to vascular niches of BM. 6 The clonal neoplastic B-cells in DLBCL recruit T cells, histiocytes and CD14+ monocytes by releasing CCL-5. Reticulin fibrosis is usually seen in HCL or PTCL. Fibroblastic proliferation is also commonly seen in BM infiltration by classic HL.7

The predominant pattern of BM infiltration by lymphomas, as reported in literature, is usually diffuse followed by focal aggregates and paratrabecular infiltrates.5, 8 Unlike our findings, Arber and George, showed focal, paratrabecular, or interstitial to diffuse patterns of BM infiltration.9 The high occurrence of diffuse infiltration, in the present study reflects the fact that patients here present at a much later stage of lymphoma progression. Table 3 shows the comparison of BMB pattern of infiltration in various studies.5

Two large case series of bone marrow involvement by lymphomas are by Sovani et al3 and Arber and George,9 on 511 and 450 cases, respectively. In both their series, FL was the commonest lymphoma subtype to involve marrow, which was 26% and 30% respectively. Paratrabecular and mixed pattern of infiltration was common. In the present study, intrasinusoidal infiltration was seen in only 2.35% of cases and that too only with SMZL and HTCL. Arber and George, included sinusoidal infiltration as a part of interstitial infiltration.9 Various other studies also show a wide variation in estimating occurrence of intrasinusoidal pattern. However, most of them consider it as pathognomonic of SMZL.3, 10, 11

In 42.9% of our cases BMB was diagnostic of lymphoma and bone was the first site of tissue diagnosis, these included mainly the low grade lymphomas comprising of FL, LPL and CLL/SLL. In all of these, BM along with immunophenotyping was useful in subcategorizing the lymphoma, precluding the need for a lymph node biopsy. Recently PET/CT has developed as an important tool in the assessment of marrow infiltration by lymphomas. Studies on PET-CT conclude that although BMB remains the best method in patients with indolent lymphomas, it may not be performed in patients diagnosed with HL and DLBCL, where PET-CT is positive.12, 13 The study by Ozpolat et al suggested that lymphoma infiltration should not be decided solely based PET-CT or BMB findings. Both BMB and PET-CT along with clinical and laboratory findings should be used synergistically. PET-CT is useful for predicting lymphoma infiltration in BM in patients for whom BMB is contraindicated.14

Conclusion

Atypical lymphoid cells may not be present at times in peripheral blood or bone marrow aspirate inspite of infiltration in the bone marrow. BMB is more sensitive than BMA for lymphoma infiltration and is the gold standard for identification of lymphoma infiltration in BM. Different lymphomas often demonstrate characteristic patterns of marrow involvement and secondary changes which can help in differentiating them from each other.

Source of Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflicts of Interest

None to declare.

References

1 

B Dupas K Augeul-Meunier E Frampas C Bodet-Milin T Gastinne S Le Gouill Staging and monitoring in the treatment of lymphomasDiagn Interv Imaging20139421455710.1016/j.diii.2012.12.009

2 

SH Swerdlow E Campo NL Harris ES Jaffe SA Pileri H Stein WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition)IARC press, Lyon2017

3 

V Sovani C Harvey AP Haynes AK Mcmillan DM Clark SR O’ Connor Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findingsJ Clin Pathol20146753899510.1136/jclinpath-2013-201520

4 

BJ Bain Bone marrow trephine biopsyJ Clin Pathol200154107374210.1136/jcp.54.10.737

5 

S Sultan N Baloch Z A Ahmed S M Irfan S Parveen Pattern of bone marrow involvement in non Hodgkin's lymphoma classified according to WHO classification: Report of a developing country PakistanJ Lab Physicians2018101172010.4103/JLP.JLP_9_17

6 

C Tripodo S Sangaletti P Piccaluga S Prakash G Franco I Borrello The bone marrow stroma in hematological neoplasms--a guilty bystanderNat Rev Clin Oncol2011884566610.1038/nrclinonc.2011.31

7 

M Cacciatore C Guarnotta M Calvaruso S Sangaletti AM Florena V Franco Microenvironment-centred dynamics in aggressive B-cell lymphomasAdv Hematol201210.1155/2012/138079

8 

J Ishtiaq K Jehanzeb N Ali M Alam Bone marrow infiltration and patterns in previously diagnosed patients of Non Hodgkin Lymphoma (a single centre study)Pak Armed Forces Med J201767224952

9 

DA Arber TI George Bone marrow biopsy involvement by non-Hodgkin’s lymphoma: Frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimensAm J Surg Pathol2005291215495710.1097/01.pas.0000182405.65041.8b

10 

E Boveri L Arcaini M Merli F Passamonti S Rizzi L Vanelli Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patientsAnn Oncol20092011293610.1093/annonc/mdn563

11 

V Costes E Duchayne J Taib C Delfour T Rousset P Baldet Intrasinusoidal bone marrow infiltration: a common growth pattern for different lymphoma subtypesBr J Haematol200211949162210.1046/j.1365-2141.2002.03934.x

12 

M Goçer E Kurtoglu Comparison of Bone Marrow Involvement with Bone Marrow Biopsy and PET-CT and Evaluation of Any Effects on Survival in Patients Diagnosed with Hodgkin and Non-Hodgkin LymphomaIndian J Hematol Blood Transfus202137152910.1007/s12288-020-01284-x

13 

F Yilmaz N Soyer D Kiper R Savas N Ozsan F Şahin The role of PET/CT in evaluation of bone marrow involvement in lymphoma patients at the initial stagingMarmara Med J2017301710.5472/marumj.299374

14 

HT Ozpolat E Yilmaz HS Goksoy S Ozolpat O Dogan S N Unal Detection of bone marrow involvement with FDG PET/CT in patients with newly diagnosed lymphomaBlood Res2018534281710.5045/br.2018.53.4.281



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 06-09-2022

Accepted : 17-10-2022


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.jdpo.2022.053


Article Metrics






Article Access statistics

Viewed: 1623

PDF Downloaded: 917



Medical Abbreviation List